XTLB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

XTL Biopharmaceuticals (XTLB) Ownership - Who owns XTL Biopharmaceuticals?

XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

5 Badner Street

Phone

+972 36116600

Employees

Web

https://www.xtlbio.com

Details

Group

Domestic Stock Funds

Fundamentals

XTLB

Capitalization

11M

P/E Ratio

N/A

Risk (Beta)

1.40

Dividend Yield

N/A

Total Cash

133K

Total Cash/Share

0.02

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.03%

Revenue

ROE

N/A

Book Value

2.71M

P/B Ratio

1.96

Cash Flow

N/A

Earnings

-0.03

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

14.1M

Current Ratio

11.43

Current Revenue Per Employee

23916.67

Dividends Per Share - Security

N/A

EBITDA

630K

Float

N/A

Float - Current

N/A

Gross Income Margin

57.84

Revenue To Assets

-12.10

Shares Held By Institutions

75.1K

Shares Outstanding - Current

8.81M

Total Liabilities

223K

Total Volume MTD

N/A

Value

N/A

Gain YTD

-39.283

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of therapeutics to treat hepatitis and other infectious diseases, using human antibodies and synthetic chemicals

Industry Biotechnology